Search
English
Login
ALS closes its acquisition of Analytical Solutions (AS) in India
AS is an industry leader in performing extractable & leachable and in-vitro studies in India. Founded in 2003 and with operations based in Mumbai, Maharashtra, India, AS offers a specialized range of analytical studies, method development, and validations focused on product registration and quality control. AS also provides quality assurance and R&D support for pharmaceutical and manufacturing divisions in India and worldwide.
The AS team joins ALS with a wealth of expertise and experience, plus six successful USFDA inspections in the last 20 years. As part of ALS, the AS management team will continue their leadership role for the AS business. The business complements ALS operations in India, positioning ALS as the market leader in the region's pharmaceutical testing industry. The acquisition also underscores ALS’ commitment to expanding its global network of analytical services laboratories, with substantial additional growth anticipated in India.
Malcolm Deane, ALS CEO, said, "We warmly welcome AS to the ALS team as they join us in our pursuit of excellence in the comprehensive pharmaceutical testing market. With their extensive technical expertise, proven track record of quality compliance, and unwavering commitment to client satisfaction, AS further reinforces ALS' position as an industry leader. Through this acquisition, we can leverage our combined capabilities to deliver an even broader range of advanced analytical solutions to our clients, setting new customer service and innovation standards."
Nitin Kabbin, Analytical Solutions’ MD, noted, "We are excited to bring our expertise and unique capabilities to the ALS network. Our team's specialized knowledge and skills will enable us to significantly contribute to ALS' impressive portfolio, providing clients with even more tailored solutions. We look forward to leveraging our strengths and working closely with the ALS network to drive growth and success in the pharmaceutical testing market."
The AS team joins ALS with a wealth of expertise and experience, plus six successful USFDA inspections in the last 20 years. As part of ALS, the AS management team will continue their leadership role for the AS business. The business complements ALS operations in India, positioning ALS as the market leader in the region's pharmaceutical testing industry. The acquisition also underscores ALS’ commitment to expanding its global network of analytical services laboratories, with substantial additional growth anticipated in India.
Malcolm Deane, ALS CEO, said, "We warmly welcome AS to the ALS team as they join us in our pursuit of excellence in the comprehensive pharmaceutical testing market. With their extensive technical expertise, proven track record of quality compliance, and unwavering commitment to client satisfaction, AS further reinforces ALS' position as an industry leader. Through this acquisition, we can leverage our combined capabilities to deliver an even broader range of advanced analytical solutions to our clients, setting new customer service and innovation standards."
Nitin Kabbin, Analytical Solutions’ MD, noted, "We are excited to bring our expertise and unique capabilities to the ALS network. Our team's specialized knowledge and skills will enable us to significantly contribute to ALS' impressive portfolio, providing clients with even more tailored solutions. We look forward to leveraging our strengths and working closely with the ALS network to drive growth and success in the pharmaceutical testing market."
Update 24 AUG 2023
ALS Limited has completed the acquisition of Analytical Solutions (AS) in India, which was first signed and announced in May. With the closing of the acquisition, AS is now a part of ALS, adding its extensive expertise to ALS’ operations in India and positioning ALS as the market leader in the region's pharmaceutical testing industry.